| 8.0 |
24.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 6.9 |
48.6 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 6.7 |
26.8 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 5.9 |
17.6 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 5.3 |
15.9 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 5.0 |
20.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 4.5 |
22.7 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 4.4 |
13.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 4.4 |
13.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
| 4.4 |
17.5 |
GO:0021586 |
pons maturation(GO:0021586) |
| 4.3 |
12.9 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 4.1 |
16.5 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) |
| 4.0 |
11.9 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 3.9 |
35.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 3.9 |
15.4 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 3.7 |
18.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 3.7 |
22.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 3.6 |
14.3 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 3.6 |
21.3 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 3.5 |
10.6 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 3.5 |
10.4 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 3.3 |
10.0 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 3.2 |
19.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 3.2 |
15.9 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 3.0 |
12.1 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.0 |
9.0 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 3.0 |
9.0 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 3.0 |
17.8 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 2.9 |
8.8 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 2.9 |
8.6 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 2.9 |
8.6 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 2.7 |
8.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 2.6 |
7.9 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 2.6 |
7.9 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.6 |
13.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 2.6 |
28.7 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 2.6 |
69.4 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 2.5 |
55.0 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 2.5 |
2.5 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 2.5 |
2.5 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 2.5 |
4.9 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 2.5 |
12.3 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 2.4 |
7.3 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 2.4 |
4.9 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 2.4 |
7.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 2.3 |
2.3 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 2.3 |
7.0 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 2.3 |
18.5 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 2.3 |
11.6 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 2.3 |
27.7 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 2.2 |
9.0 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 2.2 |
35.0 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 2.2 |
6.5 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 2.2 |
6.5 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.2 |
8.6 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 2.1 |
14.9 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.1 |
18.8 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 2.1 |
6.2 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 2.1 |
10.4 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 2.1 |
14.5 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 2.0 |
2.0 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 2.0 |
10.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 2.0 |
2.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 2.0 |
5.9 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 1.9 |
5.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 1.9 |
5.8 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.9 |
3.8 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.9 |
5.7 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 1.8 |
7.4 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 1.8 |
5.5 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.8 |
11.0 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 1.8 |
5.5 |
GO:0046959 |
habituation(GO:0046959) |
| 1.8 |
3.6 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 1.8 |
5.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.7 |
7.0 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 1.7 |
5.2 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.7 |
8.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 1.7 |
12.0 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.7 |
6.8 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 1.7 |
13.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.7 |
3.4 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 1.7 |
15.3 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.7 |
6.8 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.7 |
3.3 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.7 |
6.7 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.6 |
4.9 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.6 |
1.6 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 1.6 |
8.2 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 1.6 |
1.6 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 1.6 |
13.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 1.6 |
6.5 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 1.6 |
4.8 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 1.6 |
8.0 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 1.6 |
11.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 1.6 |
4.7 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 1.6 |
9.3 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 1.6 |
21.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.5 |
7.7 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.5 |
13.9 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 1.5 |
7.7 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.5 |
13.7 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 1.5 |
13.7 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.5 |
1.5 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.5 |
4.5 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 1.5 |
2.9 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.5 |
10.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 1.5 |
10.2 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 1.4 |
5.8 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.4 |
31.6 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 1.4 |
11.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.4 |
1.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.4 |
1.4 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.4 |
4.2 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 1.4 |
5.6 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 1.4 |
8.4 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 1.4 |
5.6 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 1.4 |
16.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 1.4 |
2.8 |
GO:0061724 |
lipophagy(GO:0061724) |
| 1.4 |
4.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 1.4 |
17.8 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 1.4 |
10.9 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.3 |
10.8 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 1.3 |
10.8 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 1.3 |
12.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 1.3 |
5.3 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 1.3 |
1.3 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.3 |
2.6 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 1.3 |
9.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 1.3 |
13.0 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.3 |
10.2 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.3 |
3.8 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 1.3 |
17.7 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.2 |
6.2 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 1.2 |
2.5 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.2 |
4.9 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 1.2 |
8.5 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 1.2 |
7.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.2 |
27.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 1.2 |
2.4 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 1.2 |
2.4 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 1.2 |
10.6 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.2 |
5.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.2 |
3.5 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) |
| 1.2 |
12.9 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 1.2 |
18.7 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 1.2 |
3.5 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 1.2 |
9.3 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 1.2 |
2.3 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.2 |
3.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.1 |
13.7 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 1.1 |
17.1 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 1.1 |
2.3 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 1.1 |
20.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 1.1 |
3.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.1 |
2.3 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 1.1 |
6.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 1.1 |
5.6 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 1.1 |
8.9 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 1.1 |
3.4 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.1 |
1.1 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 1.1 |
8.9 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 1.1 |
1.1 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 1.1 |
32.0 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 1.1 |
7.7 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 1.1 |
3.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.1 |
4.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 1.1 |
2.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.1 |
2.1 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 1.1 |
11.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 1.1 |
4.2 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.1 |
7.4 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 1.1 |
17.9 |
GO:0001553 |
luteinization(GO:0001553) |
| 1.0 |
2.1 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.0 |
1.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 1.0 |
4.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 1.0 |
2.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.0 |
5.2 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 1.0 |
11.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 1.0 |
3.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.0 |
4.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 1.0 |
5.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.0 |
37.5 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 1.0 |
3.0 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 1.0 |
10.0 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 1.0 |
1.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 1.0 |
6.9 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.0 |
2.9 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 1.0 |
3.9 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.0 |
3.9 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.0 |
1.9 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 1.0 |
2.9 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 1.0 |
5.8 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 1.0 |
1.0 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.0 |
3.8 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.9 |
3.7 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.9 |
5.6 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.9 |
5.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.9 |
0.9 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.9 |
1.8 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.9 |
13.8 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.9 |
1.8 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.9 |
2.8 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 |
3.7 |
GO:0046684 |
response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.9 |
2.7 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.9 |
4.5 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.9 |
2.7 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.9 |
3.6 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.9 |
1.8 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.9 |
5.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.9 |
5.4 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.9 |
9.8 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.9 |
3.6 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.9 |
4.4 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.9 |
1.8 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.9 |
8.7 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.9 |
1.7 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.9 |
3.5 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.9 |
5.2 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.9 |
2.6 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.9 |
6.9 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.9 |
6.0 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.9 |
0.9 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.9 |
2.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.9 |
3.4 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.8 |
0.8 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.8 |
1.7 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.8 |
0.8 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.8 |
5.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.8 |
1.7 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.8 |
0.8 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.8 |
4.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.8 |
2.4 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.8 |
2.4 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.8 |
0.8 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.8 |
4.8 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.8 |
4.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.8 |
2.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.8 |
10.2 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.8 |
2.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.8 |
0.8 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.8 |
0.8 |
GO:2000662 |
interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
| 0.8 |
0.8 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) hemoglobin biosynthetic process(GO:0042541) |
| 0.8 |
15.4 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.8 |
8.5 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.8 |
3.8 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.8 |
0.8 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.8 |
6.1 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.8 |
3.0 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
| 0.8 |
3.8 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.7 |
2.2 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.7 |
1.5 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.7 |
13.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.7 |
2.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.7 |
5.1 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.7 |
2.9 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.7 |
2.9 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.7 |
2.9 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.7 |
1.4 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.7 |
1.4 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.7 |
11.5 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.7 |
5.0 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.7 |
0.7 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.7 |
2.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 |
2.8 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.7 |
2.1 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.7 |
6.4 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.7 |
3.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.7 |
2.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.7 |
1.4 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.7 |
23.0 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.7 |
2.8 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.7 |
2.1 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.7 |
2.1 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.7 |
0.7 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.7 |
1.4 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.7 |
2.7 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.7 |
2.0 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.7 |
2.7 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.7 |
4.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.7 |
4.7 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.7 |
1.3 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.7 |
2.0 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.7 |
3.3 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.7 |
2.6 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.7 |
1.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.7 |
5.3 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.7 |
9.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.7 |
2.0 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.7 |
3.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.7 |
19.6 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.6 |
7.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 |
0.6 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.6 |
2.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.6 |
1.3 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.6 |
0.6 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.6 |
4.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.6 |
4.5 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.6 |
1.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.6 |
6.3 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.6 |
2.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.6 |
1.9 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.6 |
1.3 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.6 |
1.9 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.6 |
3.1 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.6 |
4.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.6 |
12.4 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.6 |
1.2 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.6 |
0.6 |
GO:0033206 |
meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) |
| 0.6 |
4.3 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.6 |
3.7 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.6 |
2.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.6 |
6.7 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.6 |
8.5 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.6 |
0.6 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.6 |
4.3 |
GO:2000726 |
negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.6 |
1.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.6 |
4.3 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.6 |
18.8 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.6 |
45.9 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.6 |
1.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.6 |
1.8 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.6 |
5.4 |
GO:0048070 |
regulation of developmental pigmentation(GO:0048070) |
| 0.6 |
7.2 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.6 |
3.6 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.6 |
1.8 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.6 |
8.9 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.6 |
1.8 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.6 |
4.7 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.6 |
0.6 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.6 |
2.4 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of leukocyte degranulation(GO:0043302) |
| 0.6 |
0.6 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.6 |
3.5 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.6 |
7.1 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.6 |
4.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.6 |
3.5 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.6 |
2.3 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.6 |
1.7 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.6 |
0.6 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.6 |
2.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.6 |
6.8 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
| 0.6 |
3.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.6 |
6.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.6 |
0.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.6 |
4.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.6 |
6.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.6 |
8.8 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.5 |
2.7 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.5 |
1.6 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.5 |
1.6 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.5 |
11.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.5 |
8.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.5 |
0.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.5 |
6.5 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.5 |
1.1 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.5 |
2.7 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.5 |
4.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 |
2.7 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.5 |
2.1 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.5 |
4.8 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.5 |
1.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
1.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.5 |
1.6 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.5 |
1.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.5 |
1.1 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.5 |
5.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.5 |
4.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 |
5.8 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.5 |
4.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.5 |
4.1 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
3.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.5 |
0.5 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.5 |
3.6 |
GO:0044773 |
mitotic DNA damage checkpoint(GO:0044773) |
| 0.5 |
1.0 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.5 |
11.8 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.5 |
3.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
4.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.5 |
0.5 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.5 |
4.5 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.5 |
0.5 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.5 |
1.5 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.5 |
1.5 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.5 |
1.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.5 |
1.0 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.5 |
2.0 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) |
| 0.5 |
3.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.5 |
2.0 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.5 |
1.0 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.5 |
2.4 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.5 |
1.0 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.5 |
7.6 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.5 |
1.9 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.5 |
5.7 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.5 |
2.8 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.5 |
8.0 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.5 |
2.3 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.5 |
3.3 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 |
1.9 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.5 |
1.4 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.5 |
1.4 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.5 |
1.4 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.5 |
1.8 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.5 |
1.8 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.5 |
1.8 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.5 |
4.1 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.5 |
2.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.5 |
2.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.4 |
6.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
3.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.4 |
9.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.4 |
1.3 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.4 |
0.4 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.4 |
4.0 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.4 |
1.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.4 |
1.3 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.4 |
3.0 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.4 |
1.7 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.4 |
1.3 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.4 |
3.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.4 |
17.3 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.4 |
2.6 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.4 |
1.7 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.4 |
3.0 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.4 |
0.9 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.4 |
1.3 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.4 |
8.6 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.4 |
3.4 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 |
2.5 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.4 |
0.8 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.4 |
16.0 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 |
2.5 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.4 |
0.8 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.4 |
8.3 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.4 |
0.8 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.4 |
1.7 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.4 |
0.8 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.4 |
0.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 |
2.5 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.4 |
2.5 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
1.6 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.4 |
4.1 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.4 |
1.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.4 |
4.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.4 |
0.8 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.4 |
0.4 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.4 |
0.4 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.4 |
4.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
1.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.4 |
1.2 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.4 |
1.6 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.4 |
7.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.4 |
6.7 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.4 |
1.2 |
GO:1904526 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.4 |
1.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.4 |
1.2 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.4 |
1.2 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.4 |
1.2 |
GO:1903748 |
negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.4 |
0.4 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.4 |
0.8 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.4 |
12.3 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.4 |
1.9 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.4 |
1.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.4 |
11.1 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.4 |
1.9 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.4 |
2.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.4 |
1.9 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.4 |
1.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.4 |
2.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.4 |
4.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.4 |
1.9 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 |
2.6 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.4 |
0.7 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.4 |
1.5 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.4 |
6.0 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.4 |
2.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
1.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 |
2.6 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.4 |
7.0 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.4 |
1.5 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.4 |
0.4 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.4 |
1.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 |
6.1 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.4 |
2.9 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.4 |
2.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.4 |
1.4 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.4 |
0.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.4 |
2.8 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.4 |
1.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.4 |
3.2 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.3 |
0.7 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
1.7 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
3.1 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
0.7 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.3 |
1.7 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.3 |
0.7 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.3 |
0.7 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.3 |
1.0 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.3 |
0.7 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.3 |
2.0 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 |
1.4 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.3 |
0.3 |
GO:0051709 |
regulation of killing of cells of other organism(GO:0051709) |
| 0.3 |
2.0 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.3 |
1.0 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
1.7 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
4.0 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.3 |
2.0 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
1.0 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.3 |
1.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
2.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
1.6 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.3 |
2.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 |
3.6 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.3 |
3.5 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.3 |
7.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 |
1.0 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.3 |
1.6 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.3 |
0.6 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.3 |
0.6 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.3 |
0.9 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.3 |
1.6 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.3 |
1.6 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.3 |
1.6 |
GO:0046621 |
negative regulation of organ growth(GO:0046621) |
| 0.3 |
1.5 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.3 |
5.6 |
GO:0044088 |
regulation of vacuole organization(GO:0044088) |
| 0.3 |
0.9 |
GO:0090239 |
regulation of histone H4 acetylation(GO:0090239) |
| 0.3 |
4.9 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 |
1.2 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.3 |
5.5 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 |
2.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 |
1.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
1.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
2.1 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.3 |
0.6 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 |
1.2 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.3 |
1.5 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
1.8 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.3 |
2.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.3 |
4.7 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.3 |
0.9 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.3 |
4.4 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.3 |
1.5 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.3 |
2.6 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
2.0 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
1.5 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.3 |
1.7 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 |
7.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.3 |
0.9 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 |
16.6 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.3 |
0.3 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.3 |
2.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.3 |
1.4 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.3 |
0.3 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.3 |
1.9 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.3 |
0.8 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.3 |
1.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
14.7 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.3 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.3 |
3.9 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.3 |
2.5 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.3 |
1.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.3 |
0.5 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.3 |
1.6 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.3 |
0.5 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.3 |
1.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 |
3.0 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.3 |
0.8 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
2.4 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.3 |
0.8 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of epidermis development(GO:0045683) |
| 0.3 |
2.9 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.3 |
0.3 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.3 |
1.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
1.8 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
1.0 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
3.9 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 |
1.5 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 |
1.5 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.3 |
1.0 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
0.8 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.3 |
6.9 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
1.5 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.3 |
1.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
12.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.3 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
1.3 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.3 |
1.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.2 |
5.7 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
1.7 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
1.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.2 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
1.0 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
0.7 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
2.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
0.5 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 |
2.9 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.2 |
1.4 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.2 |
3.5 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 |
0.9 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.2 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.2 |
1.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.7 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.7 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
1.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
0.9 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.2 |
1.8 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.2 |
1.1 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 |
1.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
0.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
1.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.4 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.2 |
1.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
4.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
1.7 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
4.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
0.9 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.2 |
1.9 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 |
0.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 |
0.6 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
0.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
0.8 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
0.4 |
GO:0045920 |
negative regulation of exocytosis(GO:0045920) |
| 0.2 |
3.3 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.2 |
1.2 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.2 |
1.0 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.2 |
1.8 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.2 |
1.2 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
0.6 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.2 |
1.0 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.6 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
3.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.4 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.2 |
0.8 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.2 |
1.2 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
0.8 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.2 |
1.4 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.2 |
0.6 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.2 |
0.8 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 |
1.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.6 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.2 |
0.4 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 |
1.7 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
0.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.2 |
0.6 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
2.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
2.6 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 |
0.7 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
0.7 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 0.2 |
0.7 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
2.7 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.2 |
1.4 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
0.4 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.7 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
0.7 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.2 |
9.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.2 |
2.8 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.2 |
1.7 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 |
14.3 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.2 |
0.2 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.2 |
0.5 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.2 |
0.2 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 |
0.5 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
1.9 |
GO:0034694 |
response to prostaglandin(GO:0034694) response to prostaglandin E(GO:0034695) |
| 0.2 |
0.8 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
0.7 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.2 |
1.8 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.2 |
0.2 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.2 |
0.7 |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.2 |
0.7 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
1.5 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
1.3 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.2 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.2 |
0.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
1.9 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.2 |
1.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.2 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
2.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
2.3 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 |
2.3 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.2 |
1.7 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
1.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.4 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.3 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 |
0.4 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
0.1 |
GO:1901739 |
negative regulation of striated muscle cell differentiation(GO:0051154) regulation of myoblast fusion(GO:1901739) |
| 0.1 |
0.1 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.1 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
1.8 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.1 |
1.4 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
1.0 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.6 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.9 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
3.9 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.8 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
1.4 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
0.1 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 |
0.9 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
1.5 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.4 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
2.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
1.5 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.4 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 |
1.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.8 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.1 |
16.5 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.1 |
0.8 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.1 |
GO:0010870 |
positive regulation of receptor biosynthetic process(GO:0010870) |
| 0.1 |
1.5 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 |
0.5 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
0.2 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
1.9 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
0.5 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.1 |
0.5 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
1.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
1.3 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 |
0.5 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
1.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
1.5 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
5.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
2.2 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.8 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
1.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.8 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.4 |
GO:1900116 |
sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 |
0.6 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.4 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.1 |
1.0 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
1.4 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
4.9 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
1.3 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 |
0.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.6 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.7 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.8 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 |
3.7 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.1 |
0.6 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.4 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
1.2 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.1 |
0.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.3 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.1 |
0.1 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.3 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.6 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
1.8 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
4.8 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
1.4 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.4 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
1.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.8 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.8 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
1.0 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.9 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.4 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
2.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.5 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.3 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
1.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.7 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
5.3 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.1 |
0.3 |
GO:0042119 |
neutrophil activation(GO:0042119) |
| 0.1 |
0.2 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.4 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.2 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
0.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
6.1 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.6 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
1.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
1.0 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.5 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.3 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.3 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.6 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
1.5 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.7 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.4 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
1.1 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.1 |
0.3 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.3 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
0.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.6 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.8 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.1 |
0.1 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
0.3 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.1 |
0.4 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.1 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.2 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.3 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 |
0.5 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.4 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.4 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.2 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
0.4 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.1 |
1.1 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.1 |
0.5 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.2 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.2 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.1 |
GO:0071223 |
response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
| 0.1 |
0.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.3 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
0.4 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.5 |
GO:0046456 |
icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
| 0.1 |
0.3 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
1.9 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.0 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.0 |
0.2 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.5 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.7 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.0 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 |
0.3 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.0 |
0.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.2 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0045628 |
T-helper 2 cell differentiation(GO:0045064) regulation of T-helper 2 cell differentiation(GO:0045628) |
| 0.0 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.2 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.0 |
0.1 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.0 |
0.0 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.0 |
0.3 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.0 |
GO:0090174 |
organelle membrane fusion(GO:0090174) |
| 0.0 |
0.2 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.0 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 |
0.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.0 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.2 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.0 |
0.8 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.0 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.4 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
| 0.0 |
0.2 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 |
0.1 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.0 |
0.0 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.1 |
GO:0015846 |
polyamine transport(GO:0015846) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.2 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
1.5 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.0 |
0.2 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.0 |
0.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.1 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.0 |
0.1 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.2 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.0 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 |
0.0 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
